Skip to main content

L020 Pill - yellow round

Pill with imprint L020 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Rabeprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L020

Rabeprazole sodium delayed-release 20 mg L020
Rabeprazole sodium delayed-release 20 mg L020

Rabeprazole Sodium Delayed-Release

20 mg
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
carnauba wax, diacetylated monoglycerides, ethylcellulose, ferric oxide yellow, ferrosoferric oxide, hydroxypropyl cellulose, hypromellose phthalate, soya lecithin, magnesium oxide, magnesium stearate, mannitol, polyethylene glycol, shellac, sodium stearyl fumarate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "L020"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.